107 related articles for article (PubMed ID: 32826458)
21. Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice.
Ng AP; Loughran SJ; Metcalf D; Hyland CD; de Graaf CA; Hu Y; Smyth GK; Hilton DJ; Kile BT; Alexander WS
Blood; 2011 Sep; 118(9):2454-61. PubMed ID: 21673349
[TBL] [Abstract][Full Text] [Related]
22. Contribution of LATS1 and LATS2 promoter methylation in OSCC development.
Ladiz MA; Najafi M; Kordi-Tamandani DM
J Cell Commun Signal; 2017 Mar; 11(1):49-55. PubMed ID: 27761802
[TBL] [Abstract][Full Text] [Related]
23. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
[TBL] [Abstract][Full Text] [Related]
24. Lats2, a putative tumor suppressor, inhibits G1/S transition.
Li Y; Pei J; Xia H; Ke H; Wang H; Tao W
Oncogene; 2003 Jul; 22(28):4398-405. PubMed ID: 12853976
[TBL] [Abstract][Full Text] [Related]
25. N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.
Yabuta N; Mukai S; Okamoto A; Okuzaki D; Suzuki H; Torigata K; Yoshida K; Okada N; Miura D; Ito A; Ikawa M; Okabe M; Nojima H
J Cell Sci; 2013 Jan; 126(Pt 2):508-20. PubMed ID: 23230145
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Significance of Large Tumor Suppressor (
Son MW; Song GJ; Jang SH; Hong SA; Oh MH; Lee JH; Baek MJ; Lee MS
J Gastric Cancer; 2017 Dec; 17(4):363-373. PubMed ID: 29302376
[TBL] [Abstract][Full Text] [Related]
27. SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.
Mei L; Qv M; Bao H; He Q; Xu Y; Zhang Q; Shi W; Ren Q; Yan Z; Xu C; Tang C; Hussain M; Zeng LH; Wu X
Oncogene; 2021 Sep; 40(35):5357-5366. PubMed ID: 34267330
[TBL] [Abstract][Full Text] [Related]
28. LATS2 Positively Regulates Polycomb Repressive Complex 2.
Torigata K; Daisuke O; Mukai S; Hatanaka A; Ohka F; Motooka D; Nakamura S; Ohkawa Y; Yabuta N; Kondo Y; Nojima H
PLoS One; 2016; 11(7):e0158562. PubMed ID: 27434182
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
Mohad V; Lungova V; Verheyden J; Thibeault SL
Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
[TBL] [Abstract][Full Text] [Related]
30. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
Furth N; Aylon Y
Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436
[TBL] [Abstract][Full Text] [Related]
31. [Expression of LATS mRNA in mantle cell lymphoma and its clinical significance].
Yu Z; Yi S; Zhang Y; Li Z; Qiu L
Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3285-8. PubMed ID: 26815349
[TBL] [Abstract][Full Text] [Related]
32. LATS tumor suppressor: a new governor of cellular homeostasis.
Visser S; Yang X
Cell Cycle; 2010 Oct; 9(19):3892-903. PubMed ID: 20935475
[TBL] [Abstract][Full Text] [Related]
33. Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
An N; Kraft AS; Kang Y
J Hematol Oncol; 2013 Jan; 6():12. PubMed ID: 23360755
[TBL] [Abstract][Full Text] [Related]
34. Zinc finger and BTB domain-containing protein 46 is essential for survival and proliferation of acute myeloid leukemia cell line but dispensable for normal hematopoiesis.
Liu YY; Xiao FF; Yang BJ; Li X; Xu SN; Chen ZW; Li P; Huang YX; Fu XM; Huang XQ; Zheng GL; Chen JP; Hou Y
Chin Med J (Engl); 2020 Jul; 133(14):1688-1695. PubMed ID: 32604177
[TBL] [Abstract][Full Text] [Related]
35. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
36. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
37. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
[TBL] [Abstract][Full Text] [Related]
38. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate.
Ménard A; Abou Nader N; Levasseur A; St-Jean G; Le Roy MLG; Boerboom D; Benoit-Biancamano MO; Boyer A
Endocrinology; 2020 May; 161(5):. PubMed ID: 32243503
[TBL] [Abstract][Full Text] [Related]
39. A novel Chk1/2-Lats2-14-3-3 signaling pathway regulates P-body formation in response to UV damage.
Okada N; Yabuta N; Suzuki H; Aylon Y; Oren M; Nojima H
J Cell Sci; 2011 Jan; 124(Pt 1):57-67. PubMed ID: 21118956
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
Song L; Huang Y; Zhang X; Han S; Hou M; Li H
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
